Latest News


Neuroscience and Pain Research

Innovative research on show.

An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The ea.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Back pain treatments shouldn’t neglect the mind.

New research by a team from the Kolling Institute has found the best treatment for chronic low back pain doesn’t just focus on the physical, but combines physiotherapy treatments with those focusing on the mind. The study, involving Emma Ho, Professor Manuela Ferreira and Lingxiao Chen, analysed evidence from almost 100 trials worldwide involving over 13,000 patients. It found a combinat.....
Read more

Category: Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence

Australia to introduce ground breaking technology to target debilitating Mito disease.

Clinicians, researchers and patients have welcomed a landmark law which will pave the way for remarkable new IVF technology to prevent mitochondrial disease. Known as “Maeve’s law” after a young Victorian girl with a rare genetic disorder, the legislation was passed by Federal Parliament allowing the specialised IVF procedure to be carried out in Australia. It will involve replacing faul.....
Read more

Category: Neuroscience and Pain Research, New Treatment, World-leading technology

Researchers identify the best way to ease chronic pain.

With large numbers of people across the community looking for effective and lasting ways to treat pain, our researchers at the Kolling Institute are driving nationally significant projects to reduce a reliance on opioid medication and promote proven alternative options. The research by our team from the Pain Management Research Centre follows the latest figures which indicate around 20 p.....
Read more

Category: Neuroscience and Pain Research, New Treatment, Research Excellence

Kolling researcher to join prestigious Harvard Medical School program.

Congratulations to Kolling Institute researcher Dr Manasi Mittinty who has been selected for the Advanced Global Clinical Scholar Research training at Harvard Medical School. Dr Mittinty is a medical trained researcher with the Pain Management and Research Centre and a University of Sydney lecturer. She has a keen interest in translation research and the connections between musculoskelet.....
Read more

Category: Musculoskeletal Research, Neuroscience and Pain Research

Living with  Parkinson's disease.

As a single mum of four children, Jo Makamaka is juggling many responsibilities. She is not complaining though, just cherishing the opportunity to look after her children and take part in a host of activities which were not always within her reach. Jo first saw a neurologist in her early-20s in response to a collection of unusual symptoms, but it was not until many years later that she w.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

World-leading research in the spotlight.

The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling. Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people. A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disord.....
Read more

Category: Neuroscience and Pain Research, Research Excellence, World-leading technology

Researchers tackle one of the nation’s biggest health challenges.

Researchers from the Kolling Institute will support an important, Australia-wide project to address the inappropriate use of medications in residential aged care. The initiative, to be co-ordinated by Monash University’s Centre for Medicine Use and Safety, has been awarded $2 million through the Medical Research Future Fund. It will see pharmacists embedded in residential aged care.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Researchers to improve diagnosis for genetic disorders .

Kolling researchers will drive a large, national research project to improve diagnostic rates for those with mitochondrial diseases and broaden treatment pathways. A $3 million grant from the Medical Research Future Fund is being invested in the project, which will involve clinicians, researchers and diagnostic scientists from a host of organisations including the Kolling and the Murdoch.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Australian first study to alleviate pain for those with spinal cord injuries.

Researchers from the Kolling Institute will partner with international and Australian experts to examine an innovative approach to nerve pain for those with spinal cord injuries. The ground breaking study has been awarded more than $1.78 million through the Federal Government’s Medical Research Future Fund. Professors Ashley Craig, James Middleton and Paul Glare from the Kolling wi.....
Read more

Category: Funding support, Neuroscience and Pain Research